ITRM - iterumtx.com Annual Revenue Growth (Last Twelve Months)

Graphic logo of iterumtx.com (ITRM)

Automated contract manufacturing capacities ensure a stable output of drugs, while the current 12-month year-over-year sales trend on GURU.Markets reflects a dynamic where the indicator value is 0.00. Iterum Therapeutics plc (ITRM) relies on global raw material logistics to mitigate risks, and profits are based on licensing payments from the sale of innovative antibiotics through clinics and pharmacies.

iterumtx.com (ITRM) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 04/11/2026

iterumtx.com (ITRM) - metric breakdowns and financial figures

- current price and projected stock value:
Fundamental company valuation:iterumtx.com ITRM
Signature product of Iterum Therapeutics plc

Iterum Therapeutics plc ensures a stable output of antibiotics thanks to streamlined raw material supply chains. This 12-month year-over-year revenue growth rate measures sales dynamics by comparing current aggregate income with the same period last year. The fluctuations on this chart reflect the actual speed of the business's market expansion. Logistics optimization and the presence of raw material buffers minimize the risks of revenue declines. Stable growth confirms the resilience of the company's capital.